Medios AG

XETRA ILM1.DE

Medios AG Total Non-Current Liabilities for the year ending December 31, 2023: USD 47.15 M

Medios AG Total Non-Current Liabilities is USD 47.15 M for the year ending December 31, 2023, a -3.90% change year over year. Total non-current liabilities are the sum of long-term debt and other non-current liabilities.

Medios AG Total Non-Current Liabilities for the year ending December 31, 2022 was USD 49.06 M, a 19.02% change year over year.
Medios AG Total Non-Current Liabilities for the year ending December 31, 2021 was USD 41.22 M, a 57.07% change year over year.
Medios AG Total Non-Current Liabilities for the year ending December 31, 2020 was USD 26.24 M, a 274.00% change year over year.
Medios AG Total Non-Current Liabilities for the year ending December 31, 2019 was USD 7.02 M, a 45.71% change year over year.

Key data

Date	Total Non-Current Liabilities	Shareholders' Equity	Other Liabilities	Total Liabilities

XETRA: ILM1.DE

Medios AG

CEO	Mr. Matthias Gaertner
IPO Date	Dec. 28, 2007
Location	Germany
Headquarters	Heidestrasse 9
Employees	1,011
Sector	Healthcare
Industries Drugstores & Retail Pharmacies Biotechnology Eyewear Pharmaceuticals

Description

Medios AG, together with its subsidiaries, engages in the wholesale of specialty pharmaceutical drugs in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies; and patient-specific therapies for dispensing individually dosed tablets. The company was founded in 2016 and is based in Berlin, Germany.

Key trends

Past 5 years